Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma
Prognosis for advanced oral carcinoma remains poor. Oncolytic virotherapy uses replication-competent viruses to infect and kill only the tumor cells. However, it has been difficult to investigate the oncolytic activity of viruses against oral carcinomas in mouse models. This study established a mous...
Main Authors: | Gaku Takano, Shinichi Esaki, Fumi Goshima, Atsushi Enomoto, Yoshimi Hatano, Haruka Ozaki, Takahiro Watanabe, Yoshitaka Sato, Daisuke Kawakita, Shingo Murakami, Takayuki Murata, Yukihiro Nishiyama, Shinichi Iwasaki, Hiroshi Kimura |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Molecular Therapy: Oncolytics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770520301807 |
Similar Items
-
Oncolytic viruses as anticancer vaccines
by: Norman eWoller, et al.
Published: (2014-07-01) -
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
by: Yokoda R, et al.
Published: (2017-11-01) -
Oncolytic Virotherapy with Myxoma Virus
by: Masmudur M. Rahman, et al.
Published: (2020-01-01) -
Perspectives on immunotherapy via oncolytic viruses
by: Alberto Reale, et al.
Published: (2019-02-01) -
Oncolytic virus immunotherapy: future prospects for oncology
by: Junaid Raja, et al.
Published: (2018-12-01)